Latest news from the EMCDDA

European Drug Report 2021

09.06.2021 - the EMCDDA publishes its European Drug Report 2021, the latest annual review of the drug situation in Europe. The report offers new insights into the health and security implications of a complex and evolving drugs problem and of a drug market resilient to COVID-19 disruption.


EU measures to control 2 new cathinones

03.2022 - The European Commission has adopted measures to control 3-MMC and 3-CMC, after the risk assessments carried out by the extended Scientific Committee of the EMCDDA.

Consumptions most impacted by COVID-19

01.2022 - The EMCDDA European Web Survey on Drugs reveals that cannabis and ecstasy use are the most impacted by COVID-19 restrictions.










Quick access to the EMCDDA main publications archives



The OFDT provides an online bibliographic database on addiction.


The EMCDDA provides a database on their publications of interest.









Drugs in Europe

2021 EMCDDA European Drug Report

How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2021

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.